Literature DB >> 19610021

Mutation analysis of hepcidin and ferroportin genes in Italian prospective blood donors with iron overload.

Lorena Duca, Paola Delbini, Isabella Nava, Valentina Vaja, Gemino Fiorelli, Maria Domenica Cappellini.   

Abstract

Maintenance of iron balance is essential for humans and requires the coordinate regulation of iron transport into plasma from dietary sources in the duodenum, from recycled senescent red cells in macrophages, and from storage in hepatocytes. Hepcidin, a recently identified antimicrobial peptide produced in the liver, has been shown to play a central role in the homeostatic regulation of iron absorption and distribution [1]. It is a negative regulator of iron absorption in the small intestine and of iron release from macrophages engaged in the recycling of iron senescent erythrocytes [2]. The human hepcidin gene contains three exons that encode a 72-aa precursor (pro-hepcidin) with a characteristic furin cleavage site immediately N-terminal to the 25-aa major hepcidin species found in plasma and urine [3]. Recently, hepcidin has been shown to regulate iron homeostasis by interaction with ferroportin, an iron cellular exporter highly expressed in absorptive enterocytes, macrophages, hepatocytes, and placental cells [4].

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19610021     DOI: 10.1002/ajh.21465

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  4 in total

1.  Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.

Authors:  Roman Mayr; Andreas R Janecke; Melanie Schranz; William J H Griffiths; Wolfgang Vogel; Antonello Pietrangelo; Heinz Zoller
Journal:  J Hepatol       Date:  2010-07-17       Impact factor: 25.083

2.  Expression of an innate immune element (mouse hepcidin-1) in baculovirus expression system and the comparison of its function with synthetic human hepcidin-25.

Authors:  Yaghoub Yazdani; Hamid Sadeghi; Mohammad Alimohammadian; Alireza Andalib; Fatemeh Moazen; Abbas Rezaei
Journal:  Iran J Pharm Res       Date:  2011       Impact factor: 1.696

3.  Evidence for dimerization of ferroportin in a human hepatic cell line using proximity ligation assays.

Authors:  Gautam Rishi; Eriza S Secondes; Daniel F Wallace; V Nathan Subramaniam
Journal:  Biosci Rep       Date:  2020-05-29       Impact factor: 3.840

Review 4.  Twenty Years of Ferroportin Disease: A Review or An Update of Published Clinical, Biochemical, Molecular, and Functional Features.

Authors:  L Tom Vlasveld; Roel Janssen; Edouard Bardou-Jacquet; Hanka Venselaar; Houda Hamdi-Roze; Hal Drakesmith; Dorine W Swinkels
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.